FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to pediatric otorhinolaryngology, and can be used to predict the risk of hearing loss in children with chronic adenoiditis and exudative otitis media. Subjective complaints are assessed according to the VAS: difficulty in nasal breathing, hearing loss, a feeling of stuffiness in the ears, nasal speech and mucopurulent discharge from the nose. Tympanometry and audiometry are performed and evaluated. Concomitant pathology is assessed: allergopathology and gastrointestinal disorders, as well as artificial feeding, parents’ smoking, gestosis during pregnancy, cesarean section delivery, as well as visits to preschool institutions and the duration of the disease. The indicators are evaluated in points in accordance with Table 1 contained in the description. The values of the points received are summed up and the risk of developing hearing loss is predicted.
EFFECT: method makes it possible to predict the risk of hearing loss in children with chronic adenoiditis and exudative otitis media by assessing the complex of the most significant risk factors.
1 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT AND METHOD OF TREATING EXUDATIVE OTITIS MEDIA IN CHILDREN | 2014 |
|
RU2550966C1 |
METHOD FOR PREDISPOSITION DETERMINATION TO DEVELOPMENT OF EXUDATIVE OTITIS MEDIA | 2019 |
|
RU2698910C1 |
SCREENING METHOD FOR DETECTING HEARING DISORDERS IN PRESCHOOL CHILDREN | 2020 |
|
RU2759485C1 |
METHOD OF TREATING EXUDATIVE OTITIS MEDIA IN CHILDREN | 2010 |
|
RU2424821C1 |
METHOD FOR ASSESSING AUDITION IN PATIENTS SUFFERING FROM MIDDLE EAR PATHOLOGY | 2013 |
|
RU2534877C1 |
METHOD FOR DETERMINING EXUDATIVE OTITIS MEDIA | 2018 |
|
RU2690171C1 |
DIAGNOSTIC TECHNIQUE FOR EXUDATIVE OTITIS MEDIA | 2019 |
|
RU2693049C1 |
METHOD FOR INTEGRATED ASSESSMENT OF PREDICTED CLINICAL COURSE AND EFFECTIVENESS IN HYPERTROPHY OF PHARYNGEAL TONSIL AND CHRONIC ADENOIDITIS IN CHILDREN SHOWN BY SKIN OXIDANT/ANTIOXIDANT ACTIVITY | 2014 |
|
RU2565838C1 |
METHOD FOR NASAL MUCOUS MEMBRANES INNATE IMMUNITY DIAGNOSTICS TO JUSTIFY SELECTION OF TREATMENT FOR CHILDREN WITH ADENOID VEGETATION HYPERTROPHY | 2016 |
|
RU2623121C1 |
METHOD OF EVALUATING THE EFFECTIVENESS OF TREATMENT OF ADENOIDITIS IN PEDIATRIC PATIENTS | 2022 |
|
RU2804728C1 |
Authors
Dates
2022-07-05—Published
2021-08-10—Filed